Empowered, Handmaid, or Rejector? The Framing of Low Libido in Women according to Scholarly Investigations of Public Communication

References

• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5) (5th ed.).
   Google Scholar
• Baglia, J. (2005). The Viagra ad venture: Masculinity, media, and the performance of sexual health. Peter Lang.
   Google Scholar
• Bahri, N., Latifnejad Roudsari, R., & Azimi Hashemi, M. (2017). “Adopting self-sacrifice”: How Iranian women cope with the sexual problems during the menopausal transition. Journal of Psychosomatic Obstetrics & Gynecology, 38(3), 180–188. https://doi.org/10.1080/0167482X.2016.1216962
   PubMed Web of Science ®Google Scholar
• *Cacchioni, T. (2015a). Big Pharma, women, and the labour of love. University of Toronto Press.
   Google Scholar
• *Cacchioni, T. (2015b). The medicalization of sexual deviance, reproduction, and functioning. In J. DeLamater & R. F. Plante (Eds.), Handbook of the sociology of sexualities (pp. 435–452). Springer.
   Google Scholar
• *Chańska, W., & Grunt-Mejer, K. (2016). The unethical use of ethical rhetoric: The case of Flibanserin and pharmacologisation of female sexual desire. Journal of Medical Ethics, 42(11), 701–704. https://doi.org/10.1136/medethics-2016-103473
   PubMed Web of Science ®Google Scholar
• Conrad, P. (1992). Medicalization and social control. Annual Review of Sociology, 18(1), 209–232. https://doi.org/10.1146/annurev.so.18.080192.001233
   Web of Science ®Google Scholar
• Dan, V., Ihlen, Ø., & Raknes, K. (2019). Political public relations and strategic framing. In J. Strömbäck & S. Kiousis (Eds.), Political public relations. Concepts, principles, and applications (2nd ed., pp. 146–167). Routledge.
   Google Scholar
• Dan, V., & Raupp, J. (2018). A systematic review of frames in news reporting of health risks. Health, Risk & Society, 20(5–6), 203–226. https://doi.org/10.1080/13698575.2018.1522422
   Web of Science ®Google Scholar
• Entman, R. M. (1993). Framing: Toward clarification of a fractured paradigm. Journal of Communication, 43(4), 51–58. https://doi.org/10.1111/j.1460-2466.1993.tb01304.x
   Web of Science ®Google Scholar
• *Fahs, B. (2011). Performing sex. The making and unmaking of women’s erotic lives. State University of New York Press.
   Google Scholar
• *Fishman, J. R. (2004). Manufacturing desire: The commodification of female sexual dysfunction. Social Studies of Science, 34(2), 187–218. https://doi.org/10.1177/0306312704043028
   PubMed Web of Science ®Google Scholar
• *Fishman, J. R., & Mamo, L. (2001). What’s in a disorder: A cultural analysis of medical and pharmaceutical constructions of male and female sexual dysfunction. Women & Therapy, 24(1/2), 179–193. https://doi.org/10.1300/J015v24n01_20
   Web of Science ®Google Scholar
• *Flore, J. (2019). Intimate tablets: Digital advocacy and post-feminist pharmaceuticals. Feminist Media Studies, 19(1), 3–18. https://doi.org/10.1080/14680777.2017.1393834
   Web of Science ®Google Scholar
• Foucault, M. (1978). The history of sexuality: An introduction. Vintage.
   Google Scholar
• Ganahl, J. (2006). Sex could be just a sniff away. San Francisco Chronicle / SFGate.com. https://www.sfgate.com/living/article/Sex-could-be-just-a-sniff-away-2498018.php
   Google Scholar
• Gilbert, D., Walley, T., & New, B. (2000). Lifestyle medicines. BMJ, 321(7272), 1341–1344. https://doi.org/10.1136/bmj.321.7272.1341
   PubMedGoogle Scholar
• *Graham, C. A., Boynton, P. M., & Gould, K. (2017). Women’s sexual desire: Challenging narratives of “dysfunction”. European Psychologist, 22(1), 27–38. https://doi.org/10.1027/1016-9040/a000282
   Web of Science ®Google Scholar
• *Hartley, H. (2006). The ‘pinking’ of Viagra culture: Drug industry efforts to create and repackage sex drugs for women. Sexualities, 9(3), 363–378. https://doi.org/10.1177/1363460706065058
   Google Scholar
• Jackson, S., & Scott, S. (2001). Embodying orgasm: Gendered power relations and sexual pleasure. In E. Kaschak & L. Tiefer (Eds.), A new view of women’s sexual problems (pp. 99–110). Haworth Press.
   Google Scholar
• Jaspers, L., Feys, F., Bramer, W. M., Franco, O. H., Leusink, P., & Laan, E. T. M. (2016). Efficacy and safety of Flibanserin for the treatment of hypoactive sexual desire disorder in women. JAMA Internal Medicine, 176(4), 453–462. https://doi.org/10.1001/jamainternmed.2015.8565
   PubMed Web of Science ®Google Scholar
• Jesson, J., Matheson, L., & Lacey, F. M. (2011). Doing your literature review: Traditional and systematic techniques. Sage.
   Google Scholar
• *Joralemon, D. (2017). Exploring medical anthropology. Routledge.
   Google Scholar
• *Jutel, A., & Mintzes, B. (2017). Female sexual dysfunction. Medicalising desire. In B. M. Z. Cohen (Ed.), Routledge international handbook of critical mental health (pp. 162–168). Routledge.
   Google Scholar
• Kingsberg, S. A. (2002). The impact of aging on sexual function in women and their partners. Archives of Sexual Behavior, 31(5), 431–437. https://doi.org/10.1023/A:1019844209233
   PubMed Web of Science ®Google Scholar
• Laumann, E., Paik, A., & Rosen, R. (1999). Sexual dysfunction in the United States: Prevalence and predictors. JAMA, 281(6), 537–544. https://doi.org/10.1001/jama.281.6.537
   PubMed Web of Science ®Google Scholar
• *Loe, M. (2004a). The rise of Viagra. How the little blue pill changed sex in America. NYU Press.
   Google Scholar
• *Loe, M. (2004b). Sex and the senior woman: Pleasure and danger in the Viagra era. Sexualities, 7(3), 303–326. https://doi.org/10.1177/1363460704044803
   Google Scholar
• Lupton, D. (2000). The social construction of medicine and the body. In G. I. Albrecht, R. Fitzpatrick, & S. C. Scrimshaw (Eds.), The handbook of social studies in health and medicine (pp. 50–63). Sage.
   Google Scholar
• Marshall, B. L. (2002). ‘Hard science’: Gendered constructions of sexual dysfunction in the ‘Viagra age. Sexualities, 5(2), 131–158. https://doi.org/10.1177/1363460702005002001
   Google Scholar
• McHugh, M. C. (2006). What do women want? A new view of women’s sexual problems. Sex Roles, 54(5), 361–369. https://doi.org/10.1007/s11199-006-9006-2
   Web of Science ®Google Scholar
• McHugh, M. C., & Chrisler, J. (2015). The medicalization of women’s bodies and everyday experiences. In M. C. McHugh & J. C. Chrisler (Eds.), The wrong prescription for women (pp. 1–15). Praeger.
   Google Scholar
• Moynihan, R. (2003). The making of a disease: Female sexual dysfunction. BMJ, 326(7379), 45–47. https://doi.org/10.1136/bmj.326.7379.45
   PubMed Web of Science ®Google Scholar
• *Moynihan, R., & Cassels, A. (2006). Selling sickness. How the world’s biggest pharmaceutical companies are turning us all into patients. Nation Books.
   Google Scholar
• *Moynihan, R., & Mintzes, B. (2010). Sex, lies and pharmaceuticals. How drug companies plan to profit from female sexual dysfunction. Greystone Books.
   Google Scholar
• Neuhaus, J. (2000). The importance of being orgasmic: Sexuality, gender, and material sex manuals in the United States, 1920–1963. Journal of the History of Sexuality, 9(4), 447–473. https://www.jstor.org/stable/3704912
   PubMed Web of Science ®Google Scholar
• Overton, B. C. (2014). Ageism. In T. L. Thompson (Ed.), Encyclopedia of health communication (pp. 54–56). Sage.
   Google Scholar
• Perelman, M. A. (2016). What history can teach us about the different response to the launch of Addyi versus Viagra. Current Sexual Health Reports, 8(2), 116–120. https://doi.org/10.1007/s11930-016-0075-0
   Google Scholar
• Petticrew, M., Rehfuess, E., Noyes, J., Higgins, J. P. T., Mayhew, A., Pantoja, T., Shemilt, I., & Sowden, A. (2013). Synthesizing evidence on complex interventions: How meta-analytical, qualitative, and mixed-method approaches can contribute. Journal of Clinical Epidemiology, 66(11), 1230–1243. https://doi.org/10.1016/j.jclinepi.2013.06.005
   PubMed Web of Science ®Google Scholar
• Reese, S. D. (2001). Prologue—Framing public life: A bridging model for media research. In S. D. Reese, O. H. Gandy, & A. E. Grant (Eds.), Framing public life: Perspectives on media and our understanding of the social world (pp. 7–30). Erlbaum.
   Google Scholar
• Reuters. (2017). Valeant to sell female libido pill business back to former owners. https://www.reuters.com/article/us-valeant-pharm-in-divestiture/valeant-to-sell-female-libido-pill-business-back-to-former-owners-idUSKBN1D61OX
   Google Scholar
• *Segal, J. Z. (2015). The rhetoric of female sexual dysfunction: Faux feminism and the FDA. Canadian Medical Association Journal, 187(12), 915–916. https://doi.org/10.1503/cmaj.150363
   Web of Science ®Google Scholar
• *Segal, J. Z. (2018). Sex, drugs, and rhetoric: The case of Flibanserin for ‘female sexual dysfunction’. Social Studies of Science, 48(4), 459–482. https://doi.org/10.1177/0306312718778802
   PubMed Web of Science ®Google Scholar
• *Taylor, C. (2015). Female sexual dysfunction, feminist sexology, and the psychiatry of the normal. Feminist Studies, 41(2), 259–292. https://doi.org/10.15767/feministstudies.41.2.259
   Web of Science ®Google Scholar
• Tiefer, L. (2004). Sex is not a natural act (2nd ed.). Westview Press.
   Google Scholar
• Tiefer, L. (2006a). Female sexual dysfunction: A case study of disease mongering and activist resistance. PLoS Medicine, 3(4), e178. https://doi.org/10.1371/journal.pmed.0030178
   PubMed Web of Science ®Google Scholar
• Tiefer, L. (2006b). The Viagra phenomenon. Sexualities, 9(3), 273–294. https://doi.org/10.1177/1363460706065049
   Google Scholar
• *Tiefer, L. (2015). Women’s sexual problems: Is there a pill for that? In M. C. McHugh & J. C. Chrisler (Eds.), The wrong prescription for women: How medicine and media create a “need” for treatments, drugs, and surgery (pp. 147–159). ABC-CLIO.
   Google Scholar
• Tyler, M. (2008). Sex self-help books: Hot secrets for great sex or promoting the sex of prostitution? Women’s Studies International Forum, 31(5), 363–372. https://doi.org/10.1016/j.wsif.2008.08.007
   Web of Science ®Google Scholar
• Vares, T., & Braun, V. (2006). Spreading the word, but what word is that? Viagra and male sexuality in popular culture. Sexualities, 9(3), 315–332. https://doi.org/10.1177/1363460706065055
   Google Scholar
• Weinberger, J. M., Houman, J., Caron, A. T., & Anger, J. (2019). Female sexual dysfunction: A systematic review of outcomes across various treatment modalities. Sexual Medicine Reviews, 7(2), 223–250. https://doi.org/10.1016/j.sxmr.2017.12.004
   PubMed Web of Science ®Google Scholar
• Weis, D. L. (1998). Conclusion: The state of sexual theory. Journal of Sex Research, 3(1), 100–114. https://doi.org/10.1080/00224499809551920
   Google Scholar
• Winterich, J. A. (2003). Sex, menopause, and culture: Sexual orientation and the meaning of menopause for women’s sex lives. Gender & Society, 17(4), 627–642. https://doi.org/10.1177/0891243203253962
   Web of Science ®Google Scholar
• *Woloshin, S., & Schwartz, L. M. (2016). US food and drug administration approval of Flibanserin: “Even the Score” does not add up. JAMA Internal Medicine, 176(4), 439–442. https://doi.org/10.1001/jamainternmed.2016.0073
   PubMed Web of Science ®Google Scholar
• Wood, J. (1999). Gendered lives (3rd ed.). Cengage Learning.
   Google Scholar
• Woolhouse, H., McDonald, E., & Brown, S. (2012). Women’s experiences of sex and intimacy after childbirth: Making the adjustment to motherhood. Journal of Psychosomatic Obstetrics & Gynecology, 33(4), 185–190. https://doi.org/10.3109/0167482X.2012.720314
   PubMed Web of Science ®Google Scholar